Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Tourtellotte Solutions, a provider of bio-pharmaceutical clinical trials software, has announced the launch of its Trident IWR next-generation IWR/IVRS platform for Phase II-IV studies.
Subscribe to our email newsletter
Trident’s unique parameter driven plus custom pluggable design promises to deliver a new era of needed scalability, productivity, and ease-of-use to the global clinical IVRS market.
Ed Tourtellotte, president and CEO of Tourtellotte Solutions, said: “I believe that the time for next-generation IWR has come.”